PRESS RELEASE published on 09/04/2024 at 16:16, 14 days 10 hours ago Original-Research: Vita 34 AG (von Montega AG): Kaufen (zuvor: Halten) Montega AG stuft Vita 34 AG auf Kaufen mit erhöhtem Kursziel. Vita 34 verzeichnet leicht gesteigertes Wachstumstempo im 2. Quartal 2024 und bestätigt Guidance Montega AG Vita 34 AG Guidance Kaufen Wachstumstempo
BRIEF published on 08/30/2024 at 07:05, 19 days 19 hours ago Vita 34 AG maintient sa croissance au premier semestre 2024 et augmente fortement son cash-flow opérationnel Vita 34 AG Croissance Des Revenus Augmentation De L'EBITDA Résultats Du 1er Semestre 2024 Flux De Trésorerie D'exploitation
BRIEF published on 08/30/2024 at 07:05, 19 days 19 hours ago Vita 34 AG Sustains Growth in H1 2024, Strongly Boosts Operating Cash Flow Revenue Growth Operating Cash Flow Vita 34 AG EBITDA Increase H1 2024 Results
PRESS RELEASE published on 08/30/2024 at 07:00, 19 days 19 hours ago Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow Vita 34 AG reports positive first half of 2024 with revenue growth and increased operating cash flow. EBITDA up by 76.4%. Full-year outlook confirmed EBITDA Revenue Growth Operating Cash Flow Vita 34 AG First Half Results
BRIEF published on 08/09/2024 at 17:09, 1 month 9 days ago Subsidiaries of Vita 34 Reach Agreement with US Licensor Vita 34 FamiCordTx PBKM CAR-T Technology Biotechnology Agreement
BRIEF published on 08/09/2024 at 17:09, 1 month 9 days ago Les filiales de Vita 34 concluent un accord avec un concédant de licence américain Vita 34 FamiCordTx PBKM Technologie CAR-T Accord Sur Les Biotechnologies
PRESS RELEASE published on 08/09/2024 at 17:04, 1 month 9 days ago EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor Vita 34 AG subsidiaries reach agreement with US licensor on CAR-T technology, settling previous lawsuit and securing new know-how licensing agreement Vita 34 AG Agreement Subsidiaries CAR-T Technology US Licensor
BRIEF published on 08/01/2024 at 12:44, 1 month 17 days ago Thomas Pfaadt Appointed as New Chief Financial Officer of Vita 34 AG Chief Financial Officer Finance Management Board Vita 34 AG Thomas Pfaadt
BRIEF published on 08/01/2024 at 12:44, 1 month 17 days ago Thomas Pfaadt nommé nouveau directeur financier de Vita 34 AG Conseil D'administration Finance Vita 34 AG Directeur Financier Thomas Pfaadt
PRESS RELEASE published on 08/01/2024 at 12:39, 1 month 17 days ago Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG Thomas Pfaadt appointed as new CFO of Vita 34 AG, bringing 20+ years of experience. Management Board complete. Vita 34, leading cell bank in Europe, focusing on cell banking and investments in therapies CFO Vita 34 AG Investments Thomas Pfaadt Cell Banking
Published on 09/18/2024 at 23:10, 3 hours 9 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 3 hours 19 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 4 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 5 hours 19 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 9 hours 49 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 7 hours 7 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 7 hours 33 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 7 hours 47 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 5 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 8 hours 57 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 7 hours 33 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 7 hours 33 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 8 hours 39 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.